442562-80-3 Usage
Uses
Used in Pharmaceutical Research:
3-(1H-Indol-4-yl)benzoic acid is used as a precursor in the synthesis of biologically active compounds for pharmaceutical research, due to its potential anti-inflammatory, anti-tumor, and anti-cancer properties. It serves as a valuable target for the development of new drugs that can address these health concerns.
Used in Organic Synthesis:
In the field of organic synthesis, 3-(1H-Indol-4-yl)benzoic acid is used as a key intermediate for the production of various organic compounds, leveraging its structural features to create a wide range of chemical entities.
Used in Dye and Pigment Production:
3-(1H-Indol-4-yl)benzoic acid is utilized as a component in the manufacturing of dyes and pigments, capitalizing on its chemical properties to contribute to the color and stability of these products.
Used in Chemical Research:
In the realm of chemical research, particularly in the study of indoles and their derivatives, 3-(1H-Indol-4-yl)benzoic acid is employed as a subject of investigation. This helps in understanding the properties and potential applications of indole-containing compounds in various scientific and industrial contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 442562-80-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,2,5,6 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 442562-80:
(8*4)+(7*4)+(6*2)+(5*5)+(4*6)+(3*2)+(2*8)+(1*0)=143
143 % 10 = 3
So 442562-80-3 is a valid CAS Registry Number.
442562-80-3Relevant academic research and scientific papers
MALIC ENZYME INHIBITORS
-
Page/Page column 115-116, (2021/04/23)
The present invention relates to novel compounds useful as malic enzyme (ME) inhibitors, processes for their preparation and use of these compounds for the therapeutic treatment of disorders mediated by ME such as cancers (e.g. pancreatic ductal adenocarcinoma (PDAC)) in humans.
4-aryl substituted indolinones
-
, (2008/06/13)
The present invention relates to 4-arylindolinones, as well as pharmaceutical compositions thereof, capable of modulating protein kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. The present invention also relates to methods for treating protein kinase related disorders.
